Baader Bank Aktiengesellschaft’s Edwards Lifesciences EW Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-116,500	Closed	-$11M	–	376
2023 Q2	$11M	Buy	+116,500	New	+$10.1M	0.56%	69
2023 Q1	–	Sell	-236,000	Closed	-$17.7M	–	409
2022 Q4	$17.7M	Buy	+236,000	New	+$18.2M	0.86%	42
2022 Q3	–	Sell	-81,700	Closed	-$4.06M	–	352
2022 Q2	$4.06M	Buy	+81,700	New	+$8.46M	0.31%	73

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Baader Bank Aktiengesellschaft's EW Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its Edwards Lifesciences (EW) stake by 7.2% in Q1 2026, selling an estimated $484K and leaving 75,561 shares worth $6.04M. The position accounts for 0.47% of the portfolio, ranked #48.

Baader Bank Aktiengesellschaft first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.8M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Baader Bank Aktiengesellschaft held 75,561 shares of Edwards Lifesciences worth $6.04M as of Q1 2026.
Baader Bank Aktiengesellschaft sold 5,867 Edwards Lifesciences shares in Q1 2026, an estimated $484K.
Edwards Lifesciences made up 0.47% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #48 holding.
Baader Bank Aktiengesellschaft first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
Baader Bank Aktiengesellschaft's Edwards Lifesciences position peaked at $13.8M in Q1 2024.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.